This is a working overview of heptapeptide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-05 and is reviewed periodically as new material appears.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
| Property | Value | Notes |
|---|---|---|
| Reported sequence | Ac-LKKTETQ | Described in most listings as the actin-binding region of thymosin beta-4 |
| Reported molecular weight | Approximately 889 Da | Value shifts with the stated sequence; compare against the certificate of analysis |
| Parent protein length | 43 amino acids | Thymosin beta-4; the fragment covers only a small part of it |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Trade-style names rather than formal nomenclature |
| Formal monographs | Not established | Labeling conventions differ by supplier and region |
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
=== Pharmacodynamics === Oveporexton acts as a selective agonist of the orexin OX2 receptor. Oveporexton has wakefulness-promoting effects in animals, including in rodents and monkeys. In addition, oveporexton has been found to be effective in the treatment of narcolepsy and cataplexy in phase 3 clinical trials in humans. Oveporexton is a first-in-class medication and targets the root symptomatic cause of narcolepsy type 1 by remediating the orexin (hypocretin) deficiency that is present in the condition.
Progress in Engineering Application and Technology. 2 (2): 732–751. eISSN 2773-5303. Archived from the original on 1 June 2025 – via Universiti Tun Hussein Onn. Pahrurodji, Purwanti (6 August 2021). Dari Dapur Rumput Laut: Makananmu adalah Obatmu dan Obatmu adalah Makananmu [From the Kitchen of Seaweed: Your Food is Your Medicine and Your Medicine is Your Food] (in Indonesian). Pimedia. ISBN 978-623-6488-06-5. A. Jalalal, Syamimi (2022). EFFICACY OF COMMERCIAL GAMAT EXTRACT (Stichopus variegatus) PREPARATION ON STRAY CATS WITH GASTROINTESTINAL HELMINTHIASIS. Degree of Doctor of Veterinary Medicine (Thesis) (in Malay). pp. 1–112. Archived (PDF) from the original on 2 June 2025. Retrieved 2 June 2025 – via Universiti Malaysia Kelantan. Alpayet, Rahmat; Andi Mustika, Aulia; Rahma, Anisa; Andriyanto, Andriyanto; Noviyanti Sutardi, Lina (2023). "Penyembuhan luka sayatan menggunakan krim ekstrak teripang laut dan kunyit" [Healing of incision wound using sea cucumber and turmeric extracts cream]. Current Biomedicine (in Indonesian). 1 (2): 732–751. doi:10.29244/currbiomed.1.2.54-61. eISSN 2985-4784. Archived from the original on 1 June 2025 – via IPB University, Bogor, Indonesia.
John Lilley states, "...neutron-induced fission generates extra neutrons which can induce further fissions in the next generation and so on in a chain reaction. The chain reaction is characterized by the neutron multiplication factor k, which is defined as the ratio of the number of neutrons in one generation to the number in the preceding generation. If, in a reactor, k is less than unity, the reactor is subcritical, the number of neutrons decreases and the chain reaction dies out. If k > 1, the reactor is supercritical and the chain reaction diverges. This is the situation in a fission bomb where growth is at an explosive rate. If k is exactly unity, the reactions proceed at a steady rate and the reactor is said to be critical. It is possible to achieve criticality in a reactor using natural uranium as fuel, provided that the neutrons have been efficiently moderated to thermal energies." Moderators include light water, heavy water, and graphite. According to John C. Lee, "For all nuclear reactors in operation and those under development, the nuclear fuel cycle is based on one of three fissile materials, 235U, 233U, and 239Pu, and the associated isotopic chains. For the current generation of LWRs, the enriched U contains 2.5~4.5 wt% of 235U, which is fabricated into UO2 fuel rods and loaded into fuel assemblies." Lee states, "One important comparison for the three major fissile nuclides, 235U, 233U, and 239Pu, is their breeding potential.
=== Preregistration === AIP-201 – positron-emission tomography (PET) enhancer – diagnosis [1] Levodopa/carbidopa subcutaneous (ND-0612; ND-0680) – combination of levodopa (dopamine precursor) and carbidopa (aromatic L-amino acid decarboxylase (AAAD) inhibitor) [2]
Sources: en.wikipedia.org
== Causes == Point mutations usually take place during DNA replication. DNA replication occurs when one double-stranded DNA molecule creates two single strands of DNA, each of which is a template for the creation of the complementary strand. A single point mutation can change the whole DNA sequence. Changing one purine or pyrimidine may change the amino acid that the nucleotides code for. Point mutations may arise from spontaneous mutations that occur during DNA replication. The rate of mutation may be increased by mutagens. Mutagens can be physical, such as radiation from UV rays, X-rays or extreme heat, or chemical (molecules that misplace base pairs or disrupt the helical shape of DNA). Mutagens associated with cancers are often studied to learn about cancer and its prevention. There are multiple ways for point mutations to occur. First, ultraviolet (UV) light and higher-frequency light have ionizing capability, which in turn can affect DNA. Reactive oxygen molecules with free radicals, which are a byproduct of cellular metabolism, can also be very harmful to DNA. These reactants can lead to both single-stranded and double-stranded DNA breaks. Third, bonds in DNA eventually degrade, which creates another problem to keep the integrity of DNA to a high standard. There can also be replication errors that lead to substitution, insertion, or deletion mutations.
== Principle == An HID connected to a gas chromatograph (GC) has the great advantage to use helium as both the carrier gas and the ionization gas. An HID is an ion detector which uses a radioactive source, typically β-emitters, to create metastable helium species. The radioactive source ionizes helium atoms by bombarding them with emissions. The metastable helium species have an energy of up to 19.8 eV. These metastable helium species can ionize all compounds with the exception of neon which has a greater ionization potential of 21.56 eV. As components elute from the GC's column they collide with the metastable helium ions, which then ionize the components. The ions produce an electric current, which is the signal output of the detector. The greater the concentration of the component, the more ions are produced, and the greater the current.
The cells undergo freeze-drying, the dehydration being the basic cause of freezing injury. The rate of cooling has been shown to influence the frost resistance of tissues, but the actual rate of freezing will depend not only on the cooling rate, but also on the degree of supercooling and the properties of the tissue. Sakai (1979a) demonstrated ice segregation in shoot primordia of Alaskan white and black spruces when cooled slowly to 30 °C to -40 °C. These freeze-dehydrated buds survived immersion in liquid nitrogen when slowly rewarmed. Floral primordia responded similarly. Extraorgan freezing in the primordia accounts for the ability of the hardiest of the boreal conifers to survive winters in regions when air temperatures often fall to -50 °C or lower. The hardiness of the winter buds of such conifers is enhanced by the smallness of the buds, by the evolution of faster translocation of water, and an ability to tolerate intensive freeze dehydration. In boreal species of Picea and Pinus, the frost resistance of 1-year-old seedlings is on a par with mature plants, given similar states of dormancy.
During long-term use, labetalol can reduce heart rate during exercise while maintaining cardiac output by an increase in stroke volume. Labetalol possesses significant intrinsic sympathomimetic activity (ISA). In particular, it is a partial agonist at β2-adrenergic receptors located in the vascular smooth muscle. Labetalol relaxes vascular smooth muscle by a combination of this partial β2-adrenergic receptor agonism and through α1-adrenergic receptor blockade. Overall, this vasodilatory effect can decrease blood pressure. It was originally reported to lack ISA, but a slight degree of activity was subsequently characterized. Similar to local anesthetics and sodium channel blocking antiarrhythmics, labetalol also has membrane stabilizing activity. By decreasing sodium entry, labetalol decreases action potential firing and thus has local anesthetic activity.
== External links == GeneReviews/NCBI/NIH/UW entry on Hemophilia A Factor+VIII at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the structural information available in the PDB for UniProt: P00451 (Human Factor VIII) at the PDBe-KB.
Sources: en.wikipedia.org
== Waste water produced by resin regeneration == Most ion-exchange systems use columns of ion-exchange resin that are operated on a cyclic basis. During the filtration process, water flows through the resin column until the resin is considered exhausted. That happens only when water leaving the column contains more than the maximal desired concentration of the ions being removed. Resin is then regenerated by sequentially backwashing the resin bed to remove accumulated suspended solids, flushing removed ions from the resin with a concentrated solution of replacement ions, and rinsing the flushing solution from the resin. Production of backwash, flushing, and rinsing wastewater during regeneration of ion-exchange media limits the usefulness of ion exchange for wastewater treatment. Water softeners are usually regenerated with brine containing 10% sodium chloride. Aside from the soluble chloride salts of divalent cations removed from the softened water, softener regeneration wastewater contains the unused 50–70% of the sodium chloride regeneration flushing brine required to reverse ion-exchange resin equilibria. Deionizing resin regeneration with sulfuric acid and sodium hydroxide is approximately 20–40% efficient. Neutralized deionizer regeneration wastewater contains all of the removed ions plus 2.5–5 times their equivalent concentration as sodium sulfate.
Founder, Professionals with Alzheimer's. For services to Charity. Kenneth Salter. For services to the community in Ellesmere Port, Cheshire. Cheryl Anne Sanderson. For services to Cancer Patients in Barnsley, South Yorkshire. David Saunders. For services to the community in Middlesbrough, North Yorkshire. Annie Groat Scott. For services to the community in Westray, Orkney. Pamela Mary Joyce Scull (Pamela Wingfield). Founder Principal, Wingfield School of Ballet and Dance. For services to Dance and to the community in Bristol. Sanjay Shambhu. Councillor, South Gloucestershire Council and Chair, BAME Conservatives. For Political Service. John Frederick Sharman. For services to the community in Peterborough, Cambridgeshire. Janice Sheward. Director, Cancer United. For services to People with Cancer in West Sussex. Darren Keith Sims. Founder, Daz's Rock 4 Charity. For Charitable Fundraising for Disabled and Disadvantaged Young People. Ian Robert Skinner. For services to the community in Sidmouth and the Sid Valley, Devon. Angela Ann Smith. Lately Deputy Manager, Process Controls Team, Defence Business Services. For services to Defence and to Charity. Carl Smith. Advanced Paramedic in Critical Care, East of England Ambulance Service NHS Trust, Head, Clinical Development for Emergency and Critical Care, College of Paramedics and Firefighter, Norfolk Fire and Rescue Service. For services to the NHS and to Fire and Rescue. Cheryl Barbara Smith. Leader, Girlguiding Cornwall. For services to Young People. John Alexander Alister Smyth.
== Complications == LA-ICP-MS function optimally with gold particles greater than 60 μm in diameter to avoid any contamination during measurements. Although LA-ICP-MS has a lower detection limit, its overall precision was lower than other analysis techniques for trace element concentrations such as field emission-electron probe microanalysis (FE-EPMA) and synchrotron micro X-ray fluorescence spectroscopy (SR-l-XRF). Due to the small size of gold (<5μm-250μm) small fragments of minerals need to be separated from the gold before analysis can occur. Gold fingerprinting has limitations including elemental fractionation (the non-sample related analyte) and calibration requires matrix-matched standards. A few other problems exist that limit actual sourcing or provencancing of gold in relation to manufactured art objects. These problems include: a lack of an extensive database of elemental profiles in gold ores, the natural differences that coexist in ore geology and the difficulties of accurately analyzing trace elements. Also, trading, looting and re-melting of so called “precious” metal objects add to the problem of sourcing.
== PfSPZ development == In 2003 Sanaria ran trials in which falciparum sporozoites were manually dissected from salivary glands of mosquitos, irradiated and preserved before inoculation with one goal: to develop and commercialize a non-replicating, metabolically active PfSPZ vaccine. In human volunteer trials PfSPZ was applied subcutaneously (SC) or intradermally (ID) and such as it showed only modest immune response. When PfSPZ Vaccine was injected intravenously (IV) to nonhuman primates or mice it finally triggers CD8+ T-cells producing IFNγ. These T cells are believed to be the main immunologic mechanism to fight malaria in liver. Two first clinical trials of IV administration of PfSPZ were conducted in 2013. Previous ID or IC clinical trials didn't trigger adequate immune response. A 2014 phase 1 trial with the PfSPZ Vaccine found that more than half of the participants were protected from malaria infection for over a year after the trial. In 2014 Sanaria promoted an Indiegogo campaign to develop a robot that could dissect salivary glands of mosquitos, to make preparation and further development of vaccine much faster and easier. The crowdfunding campaign ended, after being backed by $45,024 of the $250,000 goal. The PfSPZ Vaccine candidate was granted fast track designation by the U.S. Food and Drug Administration in September 2016. A study published in 2017 reported complete protection after 10 weeks with three doses of PfSPZ-CVac. In April 2019, a phase 3 trial in Bioko was announced, scheduled to start in early 2020.
Sources: en.wikipedia.org
Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.
No. Thymosin beta-4 is a protein of 43 amino acids, while TB-500 is described as a short fragment of it. The two differ in size, structure, and the range of interactions each can support.
Naming for research peptides is not centrally coordinated, so vendors set their own labels and specifications. Differences in stated sequence, molecular weight, or purity documentation usually trace back to those independent labeling choices.
TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.